Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Riebel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neuroimage|May 26, 2025
Data integration with Fusion Searchlight: Classifying brain states from resting-state fMRISimon Wein, Marco Riebel, Lisa-Marie Brunner, et al.
Pharmacopsychiatry|May 23, 2023
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMSMarco Riebel, Benedikt von Pappenheim, Carolina Kanig, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 8, 2024
Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depressionMarco Riebel, Lisa-Marie Brunner, Caroline Nothdurfter, et al.
Frontiers in Neuroimaging|December 18, 2023
Inhalation-modulated detection of olfactory BOLD responses in the human brainAino-Lotta I Alahäivälä, Divesh Thaploo, Simon Wein, et al.
Frontiers in Neuroscience|December 11, 2023
Short-term effects of etifoxine on human gut microbiome in healthy menAndré Manook, Thomas C Baghai, Marco Riebel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2024
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolamSimon Wein, Marco Riebel, Philipp Seidel, et al.
Trials|April 22, 2024
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept studyLisa-Marie Brunner, Marco Riebel, Simon Wein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neuroimage|May 26, 2025
Data integration with Fusion Searchlight: Classifying brain states from resting-state fMRISimon Wein, Marco Riebel, Lisa-Marie Brunner, et al.
Pharmacopsychiatry|May 23, 2023
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMSMarco Riebel, Benedikt von Pappenheim, Carolina Kanig, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 8, 2024
Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depressionMarco Riebel, Lisa-Marie Brunner, Caroline Nothdurfter, et al.
Frontiers in Neuroimaging|December 18, 2023
Inhalation-modulated detection of olfactory BOLD responses in the human brainAino-Lotta I Alahäivälä, Divesh Thaploo, Simon Wein, et al.
Frontiers in Neuroscience|December 11, 2023
Short-term effects of etifoxine on human gut microbiome in healthy menAndré Manook, Thomas C Baghai, Marco Riebel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 31, 2024
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolamSimon Wein, Marco Riebel, Philipp Seidel, et al.
Trials|April 22, 2024
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept studyLisa-Marie Brunner, Marco Riebel, Simon Wein, et al.
Pageof 1